Literature DB >> 6674375

Summary of worldwide clinical experience with H-B-Vax (B, MSD).

A A McLean, M R Hilleman, W J McAleer, E B Buynak.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6674375     DOI: 10.1016/s0163-4453(83)96879-2

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  5 in total

Review 1.  Viral hepatitis: past and future of HBV and HDV.

Authors:  Emmanuel Thomas; Masato Yoneda; Eugene R Schiff
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-02       Impact factor: 6.915

Review 2.  Update on diagnosis, management, and prevention of hepatitis B virus infection.

Authors:  F J Mahoney
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

3.  High seroprotection rate induced by intradermal administration of a recombinant hepatitis B vaccine in young healthy adults: comparison with standard intramuscular vaccination.

Authors:  Mohammad J Ghabouli; Amir Hasan Sabouri; Naser Shoeibi; Sepideh Naghibzadeh Bajestan; H Baradaran
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

4.  Safety and immunoenhancing effect of a Chlorella-derived dietary supplement in healthy adults undergoing influenza vaccination: randomized, double-blind, placebo-controlled trial.

Authors:  Scott A Halperin; Bruce Smith; Coleen Nolan; Janet Shay; Jaroslav Kralovec
Journal:  CMAJ       Date:  2003-07-22       Impact factor: 8.262

5.  Enhancing effects of oral adjuvants on anti-HBs responses induced by hepatitis B vaccine.

Authors:  S Kuriyama; T Tsujii; S Ishizaka; E Kikuchi; K Kinoshita; K Nishimura; K Kitagami; M Yoshikawa; M Matsumoto
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.